合作者(1605)TOP 5
  • Wong,CK
  • Chan,IHS
  • Leung,TF
  • Wong,ChunKwok
  • Fok,TF
關 鍵 字
發文可能採用名字
  • 林伟基
  • 林偉基
  • Lam, Christopher Wai Kei
  • Lam, Christopher WK
  • Lam, Christopher Wai-Kei
  • Lam,Christopher
  • Lam,WK
  • Lam,WaiKei
  • LamChristopherW
  • ChristopherWKLAM
  • Lam,WaiK
  • WaiKeiLam
  • Lam,WeiKeiChristopher
  • Lam,ChrisWK
  • LamWKC
  • LamWaiKeiChristopher
  • CWK,Lam
  • LamChrisWK
  • Lam,ChristopherWeiKai
  • Lam,ChristoperWK
  • ChristopherWaiKeiLAM
  • Lam, CWK
  • Lam, Christopher WaiKei
  • Lam, Christopher Wai-kei
  • Lam, Christopher W. K.
  • Lam, Christopher W K
  • Lam, C. W. -K.
  • Lam, Wai Kei
  • Lam CWK
  • Lam, Christopher Wei Kai
  • Lam, C. W. K.
  • Lam Christopher Wai Kei
  • Lam, CW-K
  • Christopher W.K.LAM
  • Christopher W. K. LAM
  • Lam, Christopher Waikei
  • Christopher Wai Kei LAM
  • Lam, C W K
  • Lam Christopher
  • Lam Christopher W K
  • Lam C. W K
  • Lam Wai Kei
  • Lam, Waikei
  • Wai-Kei LAM
  • Wai-Kei Lam
  • Lam W. K C
  • Lam, Christoper W. K.
  • Lam, Wei Kei Christopher
  • Lam, Wai-Kei
  • Lam Christopher W.
  • Lam, Chris W. K.
  • Lam, Christopher W.K.
  • Waikei Lam
  • Lam, Wai K.
  • Lam, C. W-K
  • Lam, WK
  • Lam, W. K.
  • Lam Wai Kei Christopher
  • CWK Lam
  • Lam Christopher W.K.
  • Lam Chris W K
  • Lam, C.W.K.
  • LAM, CWK
  • LAM, WK

林偉基

醫學院(FMD)

ORCID:

ResearcherID:

成果: 652 件 | 合作者:1605 

WOS核心合集引用:21672 | H Index:70 | WOS收錄:562

CNKI收錄:30 | SCOPUS收錄:484

論文: 644  |  科研項目:5  |   專利:3

論文: 644 篇 上傳 編輯 糾錯 可能是林偉基的文章 匯出

1.Meteorin-beta/Meteorin like/IL-41 attenuates airway inflammation in house dust mite-induced allergic asthma

Gao, X, Leung, TF, W     More...

CELLULAR & MOLECULAR IMMUNOLOGY[1672-7681], Published 2022, Volume 19, Issue 2, Pages 245-259

收錄情况: WOS SCOPUS

2021影響因子:  22.100 

2.An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease

Tomlinson, B, Chow,     More...

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2022, Volume 17, Issue 12, Pages 1353-1361

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2021影響因子:  4.936 

3.Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine

Ling, JW, Chan, BCL,     More...

FRONTIERS IN MEDICINE[2296-858X], Published 2022, Volume 8,

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2021影響因子:  5.058 

4.MTBSTFA derivatization-LC-MS/MS approach for the quantitative analysis of endogenous nucleotides in human colorectal carcinoma cells

Zhang, HX, Li, Y, Li     More...

JOURNAL OF PHARMACEUTICAL ANALYSIS[2095-1779], Published 2022, Volume 12, Issue 1, Pages 77-86

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2021影響因子:  14.026 

5.The Immuno-Modulatory Activities of Pentaherbs Formula on Ovalbumin-Induced Allergic Rhinitis Mice via the Activation of Th1 and Treg Cells and Inhibition of Th2 and Th17 Cells

Li, PT, Tsang, MSM,     More...

MOLECULES[1420-3049], Published 2022, Volume 27, Issue 1,

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2021影響因子:  4.927 

6.Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections

Gao, Xun, Chu, Ida M     More...

Cell Death and Disease[2041-4889], Published 2021, Volume 12, Issue 1,

收錄情况: WOS SCOPUS

WOS核心合集引用: 18  2021影響因子:  9.696  发表年影響因子:  9.696 

7.Skewed inflammation is associated with aberrant interleukin-37 signaling pathway in atopic dermatitis

Hou, Tianheng, Tsang     More...

Allergy: European Journal of Allergy and Clinical Immunology[0105-4538], Published 2021, Volume 76, Issue 7, Pages 2102-2114

收錄情况: WOS SCOPUS

WOS核心合集引用: 8  2021影響因子:  14.710  发表年影響因子:  14.710 

8.1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection

Chen, RH, Yang, LJ,     More...

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2021, Volume 12,

收錄情况: WOS SCOPUS

WOS核心合集引用: 21  2021影響因子:  5.988  发表年影響因子:  5.988 

9.Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells

Li, Yan, Zhang, HuiX     More...

Frontiers in Pharmacology[1663-9812], Published 2021, Volume 12,

收錄情况: WOS SCOPUS

WOS核心合集引用: 2  2021影響因子:  5.988  发表年影響因子:  5.988 

10.Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia

Tomlinson, B, Patil,     More...

ENDOCRINOLOGY AND METABOLISM[2093-596X], Published 2021, Volume 36, Issue 2, Pages 279-295

收錄情况: WOS SCOPUS

WOS核心合集引用: 5  2021影響因子:  3.607  发表年影響因子:  3.607 

成果: 5 匯出
Project
成果: 3 匯出

1.治疗心脑血管疾病的药物组合物及其制备方法

易涛, 李良, 林伟基

專利權人: 澳门科技大学

申請號: CN201210308893.7 申請日: 2012/8/27

公開(公告)號: CN102805751A 公開(公告)日期: 2012/12/5

IPC分類號: A61K31/7048; A61K47/34; A61K47/44; A61P9/00

法律狀態: 未缴年费

同族信息: CN102805751A; US20140057860A1; CN102805751B; AU2013101145A4

2.一种雷公藤有效部位粉末的制备方法

林伟基, 杨祥良, 谢培山, 徐辉碧,     More...

專利權人: 澳门科技大学

申請號: CN201110139090.9 申請日: 2011/5/26

公開(公告)號: CN102793737A 公開(公告)日期: 2012/11/28

IPC分類號: A61K36/37; A61P13/12; A61K125/00

法律狀態: 未缴年费

同族信息: CN102793737B; CN102793737A

3.一种雷公藤甲素固体脂质纳米颗粒及其制备方法和应用

杨祥良, 林伟基, 徐辉碧, 易涛, 刘     More...

專利權人: 澳门科技大学

申請號: CN201110139086.2 申請日: 2011/5/26

公開(公告)號: CN102793674A 公開(公告)日期: 2012/11/28

IPC分類號: A61K9/16; A61K31/585; A61K47/44; A61K47/14; A61K47/12; A61P19/02; A61P19/04; A61P29/00; A61P13/12; A61P37/06

法律狀態: 未缴年费

同族信息: CN102793674B; CN102793674A

本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

Copyright © 2018 澳門科技大學學者庫